Drug recall · February 19, 2020
Lamotrigine Tablets recall
Why: Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1.
- Lots / codes
Lot #: 331771, Exp. June 2021
- Company
- Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY
- Distribution
- Nationwide in the U.S. and Puerto Rico.
- Initiated
- December 20, 2019 · Voluntary: Firm initiated
- Classified
- February 7, 2020
- Reported
- February 19, 2020
- Ended
- February 23, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lamotrigine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.